Sebastian Wesselborg

10PUBLICATIONS
27CO-AUTHORS
ChemotherapyMolecular targetsToxicology (incl. clinical toxicology)Biologically active moleculesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 27, 2026
Inhibition of RNA polymerase II-activating CDK9 and CDK12/13, but not of cell cycle relevant CDKs, induces apoptosis by downregulating the short-lived Bcl-2 proteins Mcl1 and Bfl1/A1.

|Dec 23, 2025
Small-molecule inhibitor of C‑terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cells.

Céline David, Yadong Sun, Vitalij Woloschin

|Mar 26, 2025
The Polybrominated Diphenyl Ether Bromoxib Disrupts Nuclear Import and Export by Affecting Nucleoporins of the Nuclear Pore Complex.

Karina S Krings, Anastasia Ritchie, Laura Schmitt

|Jan 08, 2025
Novel 4-alkoxy Meriolin Congeners Potently Induce Apoptosis in Leukemia and Lymphoma Cells.

Karina S Krings, Tobias R Wassenberg, Pablo Cea-Medina

|Jan 08, 2025
Evaluation of Genotoxic Effects of N-Methyl-N-Nitroso-Urea and Etoposide on the Differentiation Potential of MSCs from Umbilical Cord Blood and Bone Marrow.

Meryem Ouzin, Sebastian Wesselborg, Gerhard Fritz

|Jun 11, 2024
Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs).

Laura Schmitt, Julia Hoppe, Pablo Cea-Medina

Pageof 2

Frequent Collaborators

6 joint publications

Björn Stork

6 joint publications

Karina S Krings

5 joint publications

Laura Schmitt

5 joint publications

Ilka Lechtenberg